In today’s recent session, 0.71 million shares of the Immuneering Corp (NASDAQ:IMRX) have been traded, and its beta is 0.01. Most recently the company’s share price was $2.21, and it changed around $0.31 or 16.32% from the last close, which brings the market valuation of the company to $79.53M. IMRX at last check was trading at a discount to its 52-week high of $3.83, offering almost -73.3% off that amount. The share price’s 52-week low was $1.00, which indicates that the recent value has risen by an impressive 54.75% since then.
Immuneering Corp stock received a consensus recommendation rating of Buy, based on a mean score of 1.40. If we narrow it down even further, the data shows that 0 out of 6 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 1 recommended IMRX as a Hold, whereas 3 deemed it a Buy, and 0 rated it as Underweight.
Immuneering Corp (NASDAQ:IMRX) trade information
Instantly IMRX has been showing a green trend so far today with a performance of 16.32% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 2.3000 on recent trading dayincreased the stock’s daily price by 3.91%. The company’s shares are currently up 0.45% year-to-date, but still up 1.84% over the last five days. On the other hand, Immuneering Corp (NASDAQ:IMRX) is 71.98% up in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $13, which translates to bulls needing to increase their stock price by 83.0% from its current value. Analyst projections state that IMRX is forecast to be at a low of $3 and a high of $41.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -46.45%. Immuneering Corp earnings are expected to increase by 21.08% in 2025, but the outlook is positive 3.91% per year for the next five years.
IMRX Dividends
Immuneering Corp’s next quarterly earnings report is expected to be released in July.
VANGUARD GROUP INC, with 3.6442% or 1.07 million shares worth $1.37 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
